Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Tolmetin

SKU: orb1941052

Description

Tolmetin is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of tolmetin is as a Cyclooxygenase Inhibitor. The chemical classification of tolmetin is Nonsteroidal Anti-inflammatory Compounds.(In Vitro):Tolmetin (0.25 mM) does not attenuate lipid peroxidation in rat brain homogenate. Tolmetin (0.25, 0.5, 0.75, 1 mM) shows radical scavenging properties but without superoxide anion generation in rat brain homogenat.Tolmetin (0.001-100 μM) shows anticancer activity againts HT-29 colon cancer cell line in a dose-dependent manner.Tolmetin (0-100 μM) shows no effect on osteoblast growth.(In Vivo):Tolmetin (30,100 mg/kg; gavage; single dose or twice daily for 3 and 14 days) shows maximal ulcerogenic effect 4 h after the single dose, while potently decreases after 3 and 14 days of repeated administration in male Wistar rats weighing 180-200 g. Tolmetin causes gastric lesions in 100 mg/kg.Tolmetin (5 mg/kg twice a day for 5 days) pre-treatment considerably attenuates quinolinic acid (QA)-induced neurotoxicity.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number26171-23-3
MW257.28
Purity>98% (HPLC)
FormulaC15H15NO3
SMILESCN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1
TargetCOX
SolubilityDMSO: 10 mM

Bioactivity

In Vivo
Tolmetin (30, 100 mg/kg; gavage; single dose or twice daily for 3 and 14 days) shows maximal ulcerogenic effect 4 h after the single dose, while potently decreases after 3 and 14 days of repeated administration in male Wistar rats weighing 180-200 g. Tolmetin causes gastric lesions in 100 mg/kg. Tolmetin (5 mg/kg twice a day for 5 days) pre-treatment considerably attenuates quinolinic acid (QA)-induced neurotoxicity.
In Vitro
Tolmetin (0.25 mM) does not attenuate lipid peroxidation in rat brain homogenate. Tolmetin (0.25, 0.5, 0.75, 1 mM) shows radical scavenging properties but without superoxide anion generation in rat brain homogenat. Tolmetin (0.001-100 μM) shows anticancer activity againts HT-29 colon cancer cell line in a dose-dependent manner.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Amtolmetin guacil [orb1306937]

    99.85% (May vary between batches)

    87344-06-7

    420.46

    C24H24N2O5

    10 mg, 25 mg, 50 mg, 100 mg, 500 mg, 1 ml x 10 mM (in DMSO)
  • Tolmetin [orb1305327]

    >99.99% (May vary between batches)

    26171-23-3

    257.2845

    C15H15NO3

    1 ml x 10 mM (in DMSO), 50 mg, 100 mg, 500 mg, 200 mg
  • Tolmetin sodium [orb1689506]

    35711-34-3

    279.271

    C15H14NNaO3

    50 mg, 100 mg, 25 mg
  • Tolmetin β-D-Glucuronide [orb1694012]

    71595-19-2

    433.41

    C21H23NO9

    1 mg
  • Tolmetin sodium dihydrate [orb1909154]

    99.57% (May vary between batches)

    64490-92-2

    315.3

    C15H18NNaO5

    1 g, 5 g, 25 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

100 mg
200 mg
500 mg
25 mg
$ 80.00
50 mg
$ 100.00